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GROWTH OF CHILDREN IN LARGE FAMILIES.
Data were c o l l e c t e d r e t r o s p e c t i v e l y f r o m 1,811 c h i l d r e n , 6-12 y e a r s o f age, i n a r u r a l a r e a w i t h p r e d o m i n a n t l y l a r g e f a m i l i e s . Data were analyzed as p e r c e n t i l e s ( % ) f o r t h e r e s p e c t i v e ages. The mean h e i g h t s o f boys and o f g i r l s i n t h e s t u d y c o h o r t were 41.9% and 43.3%, r e s p e c t i v e l y . Height o f boys i n f a m i l i e s o f 2-3 c h i l d r e n was 47.1% (n=46), compared t o 41.8% i n f a m i l i e s o f 4-5 (n=179), 37.6% i n f a m i l i e s o f 6-7 (n=116) and 33.7% i n f a m i l i e s o f 8-14 c h i l d r e n (n=151). G i r l s ' mean h e i g h t s were 48.6%, 42.3:;, 41.52 and 42.6% i n f a m ll i e s o f 2-3, 4-5, 6-7 and 8-14 c h i l d r e n , r e s p e c t i v e l y . Weight d i d n o t d i f f e r between c h i l d r e n o f l a r g e and small f a m i l i e s . B i r t h o r d e r had no s i g n i f i c a n t e f f e c t on h e i g h t o r weight.
I n boys, a s h o r t p r e c e d i n g b i r t h i n t e r v a l o f <2 years was a s s o c i a t e d w i t h s m a l l e r mean h e i g h t s o f 37.8%, compared t o 41.8% and 43.2% when b i r t h i n t e r v a l s were 2-3 y e a r s and >3 years, r e s p e c t i v e l y . Growth o f g i r l s and w e i g h t gain o f boys and g i r l s were n o t a ff e c t e d by b i r t h i n t e r v a l s . Conclusions: 1 ) Family s t r u c t u r e has a profound e f f e c t on growth. 2 ) Growth c o r r e l a t e s w i t h s i z e o f f a m i l y and b i r t h i n t e r v a l , b u t n o t w i t h b i r t h o r d e r . 3 ) Boys a r e a f f e c t e d more t h a n g i r l s . 4) H e i g h t i s a f f e c t e d more t h a n weight, e x c l u d i n g n u t r i t i o n a l f a c t o r s . 5 ) T h i s growth d e f i c i t i s viewed as p a r t i a l psychosocial dwarfism. ;poi?se tn osmotlc, l)uL n l s u Lo tlonosn8utlr: stlolul~ :,uuh a s l~yl>o~l;i. Urlcu ~.elc,osed, A\l' is ehcrclc:<l v l n f c t~l u r r n e into Af d,r?ro 11 has a loi7q tlalf ill<: cumpored to plasma (ca 0 hour:;). T I E Ihyprlthesls of tllc 1,rcscnl study thcroforc was, that f e t s l hypoxlo rn~ql,t 11c diagnascd by clevatcd At -AVP lcvcls. As a mudel wc: usvd 1IIl:13 fetuncs %dmcl, arc known t o hc: liyl,oxlc. 25 lntants cntcred the study because LUG14 was susprcted tly ~illrssounri. Tllc norm01 A1 -AVP levls a s cunlri~l values were c!etcrrnlncd I" 95 u>compl~c,~lcd prrgnnncics Knlcre rmnloccntesis w ;~; mrformeo ror other ~.cilsons (L/5 rnLio dctc~.minatluns, o c r ? o t~c reason:;, rllscnsitircil pregnuriclr::; vllh rll-r,cgntlvc fclu.;r,r;j. lll'L valurs m:rc medsuvcd Ily l l l A as werc A1 -AVP valtle:;. Ilcsults: Tllu mnan A1 A V P lcvels i n normal I~~C~~U~C I C S frurn IG LO 41 weeks ~1 clcslatlon was 2.57 2 1.16 XI pij/m~i.Tlrerc was nu s i g n~r l c n n t difference w i l l , d,rfcrcnt gcstetlonal acje. At birth 7 or Lhc 25 lnfnnts hod rlorrni8l blrtll wv~qllt and 18 actually had 1UGll. lhere w.>s a sirjnlfic:irrL carrulatlon Ibotwr~cn the derlrov r l f IUGR ilrld A1 -AVP Icvcl:; (~=.>9,p<O.U5).llic correlation lietwcr+o Llic 111' 1. v;~lu<,:, ;~r l l l thc dogrco of llIl;l< was tho s a m a s Tor A)-AVP vaiuos (r=.>9,()<0.05). 
YETHIONn GRCNTH IlORMONE ( m t -G H ) I N A COSAGE OF 4 IU/ m2 DAY PROMOTES GRaTilI I N TUlWER SYNDROME.
I n a Dutch m u l t i -c e n t e r s t u d y 1 6 g i r l s w i t h T u r n e r Syndrome w e r e t r e a t e d w i t h met-GH i n a d o s a g e o f 4 1u/m2 body s u r f a c e a d m i n i st e r e d s.c. o n c e a d a y . I n g i r l s o l d e r t h a n 1 3 y e a r s low-dose e t h in y l -e s t r a d i o l ( E ) t h e r a p y ( 0 . 1 ug/kg M y w e i g h t 0 . d . ) was a d d e d .
Ages r a n g e d f r o m 7.9 t o 1 5 . 2 y e a r s a n d b o n e a g e f r o m 6 . 0 t o 1 2 " y e a r s " . H e i g h t s , e x p r e s s e d as s t a n d a r d d e v i a t i o n s c o r e s , w e r e bet w e e n -2.5 a n d -5.1 ( m e d i a n -3 . 9 ) . Endogenous GI1 secretion was a s s e s s e d b y a r g i n i n e i n f u s i o n , e x e r c i s e test, GRI? ( 1 -2 9 ) -t e s t a n d p l a s m a SM-C/IGF-I. W a n ( 2 S.D.) g r o w t h v e l o c i t i e s were: D a s e l i n e 0 -3 m 3 -6 m 6 -9 m 0 -9 m 3.4 ( + 0 . 8 ) 8 . 6 ( + 2 . 2 ) 6 . 4 ( A 2 . 4 ) 6.8 (5 2 . 2 ) 7 . 2 (5 1 . 6 ) --D u r i n g t h e f i r s t 6 months o f t h e r a p y t h e mean ( 5 S.D.) b o n e a g e ( G r e u l i c h a n d P y l e ) ~d v a n c e d irwn 9.1 ( 5 1 . 2 ) t o 9 . 4 (,1.2)"yi.ar. The knemometer, a n i n s t r u m e n t d e s i g n e d t o m e a s u r e i n c r e m e n t s i n l o w e r l e g l e n g t h , h a s been f u l l y a s s e s s e
d and found t o b e a p r e c i s e means o f d e t e r m i n i n g s h o r t t e r m g r o w t h p a t t e r n s . The t e c h n i q u e h a s been i n c o r p o r a t e d i n a L r i a l d e s i g n e d t o d e t e r m i n e t h e p r o p o r t i o n o f c h i l d r e n w i t h T u r n e r syndrome r e s p o n d i n g t o e x o g e n o u s Somatrem iSomatonorm), 2u d a i l y by s u b c u t a n e o u s i n j e c t i o n , f o r a 4 week p e r i o d w i t h i n a n i n t e n s i v e 13 week measurement p r o t o c o l and t o a s s e s s t h e p r e d i c t i v e v a l u e o f knemometry t o i d e n t i f y t h e s u b s e q u e n t c h a n g e i n g r o w t h v e l o c i t y measured by c o n v e n t i o n a l a u x o l o g y o v e r 6 months.
T h i r t e e n g i r l s ( 7 T u r n e r m o s a i c s ; 6 , 45x0 k a r y o t y p e ) a g e d 5;-19; y e a r s who had r e c e i v e d n o s e x s t e r o i d t h e r a p y were s t u d i e d .
E i g h t showed a n a c c e l e r a t i o n o f t i b l a l g r o w t h i n r e s p o n s e t o 4 weeks o f Somatrem t h e r a p y when compared t o a p r e -and p o s tt r e a t m e n t 4 week p e r i o d .
F o u r c h i l d r e n st:bsequcnLly showed a significant c h a n g e i n h e i g h t v e l o c i t y ( d e f i n e d a s a n i n c r e a s e o f >%cm/year o v e r t h e p r c v i o u s y c a r ' s v a l u e ) . A l l s h o r t t e r m nonr e s p o n d e r s a l s o f a i l e d t o r e s p o n d i n t h c l o n g t e r m . Only h a l f t h o s e i d e n t i f i e d a s r e s p o n d e r s i n t h e s h o r t t e r m were a l s o l o n g t e r m r e s p o n d e r s . I n t h i s s m a l l s e r i e s knernornetry was a b l e t o p r e d i c t t h o s e c h i l d r e n i n whom g r o w t h hormone t h e r a p y was n o t b e n e f i c i a l .
P.H. Heidemann, U. ~i e s e n m~l l e r : P. Stubbe. Department o f P e d i a t r i c s , U n i v e r s i t y o f Goettinqen, FRG.
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OXANDROLONE TREATMENT INCREASES FINAL ADULT HEIGHI I N TURNER'S SYNDROME.
Oxandrolone t r e a t m e n t (Ox) induces an a c c e l e r a t i o n o f g r o w t h vel o c i t y i n ~u r n e r ' s ' q n d r o m e . However, t h e e f f e c t o f such t h e r a p y on f i n a l a d u l t h e i g h t remains c o n t r o v e r s i a l . 56 p t s (age a t s t a r t o f therapy: 6 -17 y e a r s , k a r y o t y p e 45 XO: n = 32, mosaicism o r s t r u c t u r a l a b n o r m a l i t i e s : n = 24) were t r e a t e d w i t h 0.1 mg Ox/ k g l d a y f o r 2 t o 6 years. Growth v e l o c i t y and f i n a l h e i g h t were compared w i t h those o f an u n t r e a t e d c o n t r o l group (Ranke e t a1 .: Eur. J . Ped. 141, 81, 1983) . Growth v e l o c i t y was s i g n i f i c a n t l y h i g h e r i n t r e a t e d t h a n i n u n t r e a t e d p a t i e n t s ( p < 0.01) and decreased w i t h d u r a t i o n o f Rx. Bone age d i d n o t a c c e l e r a t e d u r i n g t r e a t m e n t . A f t e r 2 -6 y e a r s o f t h e r a p y 27 p t s were o l d e r t h a n 19 y e a r s . H e i g h t was s i g n i f i c a n t l y h i g h e r t h a n i n c o n t r o l s (150.8 + 5.6 vs. 146 + 5.8, p < 0.05). There was no d i f f e r e n c e between p t s w i t h k a r y o t y p e 45 XO and mosaicism o r s t r u c t u r a l l y abnormal X-chromosomes. P t s s t a r t e d w i t h Ox -Rx a t age 13 -15 y e a r s ( n = 15) seemed t o be t a l l e r t h a n p t s ( n = 10) 1 6 -1 8 y e a r s o l d a t s t a r t o f Rx (151.6 t 6.4 vs.I49,8t 4.8 cm). However, t h e d i ff e r e n c e was n o t s t a t i s t i c a l l y s i g n i f i c a n t . Our r e s u l t s i n d i c a t e t h a t Ox therapy causes a moderate, b u t s i g n i f i c a n t g a i n i n f i n a l h e i g h t i n T u r n e r ' s syndrome.
